CD74 induces TAp63 expression leading to B-cell survival

被引:69
|
作者
Lantner, Frida [1 ]
Starlets, Diana [1 ]
Gore, Yael [1 ]
Flaishon, Liat [2 ]
Yamit-Hezi, Ayala [3 ]
Dikstein, Rivka [3 ]
Leng, Lin [4 ]
Bucala, Richard [4 ]
Machluf, Yossy [2 ]
Oren, Moshe [2 ]
Shachar, Idit [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[3] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel
[4] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA
关键词
D O I
10.1182/blood-2007-04-087486
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Most mature follicular B cells circulate within the periphery in a quiescent state, without actively contributing to an acute immune response. Lasting B-cell persistence in the periphery is dependent on survival signals that are transduced by cell surface receptors. We recently demonstrated that cell surface CD74 controls mature B-cell survival. Stimulation of cell surface CD74 leads to NF-kappa B activation, which enables entry of the stimulated B cells into the S phase, induction of DNA synthesis, and cell division, and augments the expression of survival genes. In the present study, we investigated CD74 target genes to determine the identities of the molecules whose expression is modulated by CD74, thereby regulating B-cell survival. We report that CD74 activates the p65 member of the NF-kappa B family, which in turn up-regulates the expression of p53-related TAp63 proteins. TAp63 then binds and transactivates the Bcl-2 gene and induces the production of Bcl-2 protein, thereby providing the cells with increased survival capacity. Thus, the CD74/ NF-kappa B/TAp63 axis defines a novel antiapoptotic pathway in mature B cells, resulting in the shaping of both the B-cell repertoire and the immune response.
引用
收藏
页码:4303 / 4311
页数:9
相关论文
共 50 条
  • [21] Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma:: Comparison of Auger electron emitters with β-particle emitters
    Govindan, SV
    Goldenberg, DM
    Elsamra, SE
    Griffiths, GL
    Ong, GL
    Brechbiel, MW
    Burton, J
    Sgouros, G
    Mattes, MJ
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (12) : 2089 - 2097
  • [22] Immunocytochemical p63 expression discriminates between primary cutaneous follicle centre cell and diffuse large B cell lymphoma-leg type, and is of the TAp63 isoform
    Robson, Alistair
    Shukur, Zena
    Ally, Mina
    Kluk, Justine
    Liu, Kun
    Pincus, Laura
    Sahni, Debjani
    Sundram, Uma
    Subtil, Antonio
    Karai, Laszlo
    Kempf, Werner
    Schieke, Stefan
    Coates, Philip
    HISTOPATHOLOGY, 2016, 69 (01) : 11 - 19
  • [23] A role for the B-cell CD74/macrophage migration inhibitory factor pathway in the immunomodulation of systemic lupus erythematosus by a therapeutic tolerogenic peptide
    Lapter, Smadar
    Ben-David, Hava
    Sharabi, Amir
    Zinger, Heidy
    Telerman, Alona
    Gordin, Maya
    Leng, Lin
    Bucala, Richard
    Shachar, Idit
    Mozes, Edna
    IMMUNOLOGY, 2011, 132 (01) : 87 - 95
  • [24] Targeting CD74 with Novel Antibody Drug Conjugates (ADCs) for the Treatment of B-Cell Non-Hodgkin's Lymphoma (NHL)
    Li, Xiaofan
    Abrahams, Cristina
    Embry, Millicent
    Yu, Abigail
    Kahana, Jason
    Brown, Michael
    Narla, Rama Krishna
    Barnes, Leo
    Schwartz, Eric
    Boylan, John
    Zawada, James
    Stephenson, Heather
    Bruhns, Maureen
    Bussell, Stuart
    Steiner, Alexander
    Galan, Adam
    Kline, Toni
    Yam, Alice
    Stafford, Ryan
    Hoffmann, Heidi
    Matheny, Shannon
    DeAlmeida, Venita
    Vasquez, Nicki
    Heinsohn, Henry
    Sato, Aaron
    Molina, Arturo
    Hallam, Trevor
    Lupher, Mark, Jr.
    BLOOD, 2016, 128 (22)
  • [25] Association of SIRT1 and tumor suppressor gene TAp63 expression in head and neck squamous cell carcinoma
    Kikuchi, Keiji
    Noguchi, Akira
    Kasajima, Rika
    Miyagi, Yohei
    Hoshino, Daisuke
    Koshikawa, Naohiko
    Kubota, Akira
    Yokose, Tomoyuki
    Takano, Yasuo
    TUMOR BIOLOGY, 2015, 36 (10) : 7865 - 7872
  • [26] Pro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia
    Humphries, Leigh A.
    Godbersen, J. Claire
    Danilova, Olga V.
    Kaur, Prabhjot
    Christensen, Brock C.
    Danilov, Alexey V.
    BRITISH JOURNAL OF HAEMATOLOGY, 2013, 163 (05) : 590 - 602
  • [27] Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex
    Gore, Yael
    Starlets, Diana
    Maharshak, Nitsan
    Becker-Herman, Shirly
    Kaneyuki, Utako
    Leng, Lin
    Bucala, Richard
    Shachar, Idit
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (05) : 2784 - 2792
  • [28] TAp63, a methotrexate target in CD4+T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis
    Suga, Kensuke
    Suto, Akira
    Tanaka, Shigeru
    Sugawara, Yutaka
    Kageyama, Takahiro
    Ishikawa, Junichi
    Sanayama, Yoshie
    Ikeda, Kei
    Furuta, Shunsuke
    Kagami, Shin-Ichiro
    Iwata, Arifumi
    Hirose, Koichi
    Suzuki, Kotaro
    Ohara, Osamu
    Nakajima, Hiroshi
    JCI INSIGHT, 2023, 8 (10)
  • [29] Milatuzumab immunoliposomes induce cell death in CLL by promoting accumulation of CD74 on the surface of B cells
    Hertlein, Erin
    Triantafillou, Georgia
    Sass, Ellen J.
    Hessler, Joshua D.
    Zhang, Xiaoli
    Jarjoura, David
    Lucas, David M.
    Muthusamy, Natarajan
    Goldenberg, David M.
    Lee, Robert J.
    Byrd, John C.
    BLOOD, 2010, 116 (14) : 2554 - 2558
  • [30] The intramembrane protease Sppl2a is required for B cell and DC development and survival via cleavage of CD74 (P1108)
    Beisner, Daniel
    Langerak, Petra
    Parker, Albert
    Dahlberg, Carol
    Otero, Francella
    Poirot, Laurent
    Barnes, Whitney
    Young, Michael
    Niessen, Sherry
    Wiltshire, Tim
    Bodendorf, Ursula
    Martoglio, Bruno
    Cooke, Michael
    JOURNAL OF IMMUNOLOGY, 2013, 190